Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adagio Medical Holdings (ADGM) Return on Sales (2023 - 2025)

Adagio Medical Holdings has reported Return on Sales over the past 3 years, most recently at 1.84% for Q4 2025.

  • Quarterly Return on Sales changed N/A to 1.84% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.84% through Dec 2025, changed N/A year-over-year, with the annual reading at 2.35% for FY2024, 136.0% down from the prior year.
  • Return on Sales was 1.84% for Q4 2025 at Adagio Medical Holdings, down from 0.51% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.29% in Q2 2024 and troughed at 3.68% in Q1 2024.
  • The 3-year median for Return on Sales is 0.63% (2025), against an average of 1.28%.
  • The largest YoY upside for Return on Sales was 319bps in 2025 against a maximum downside of -15bps in 2025.
  • A 3-year view of Return on Sales shows it stood at 0.76% in 2023, then soared by 53bps to 0.36% in 2024, then plummeted by -416bps to 1.84% in 2025.
  • Per Business Quant, the three most recent readings for ADGM's Return on Sales are 1.84% (Q4 2025), 0.51% (Q3 2025), and 0.49% (Q1 2025).